Expert consensus on construction of pharmacovigilance system in health facilities
Center for Drug Reevaluation, National Medical Products Administration; Chinese Pharmacists Association et al
Adverse Drug Reactions Journal . 2022, (6): 284 -294 .  DOI: 10.3760/cma.j.cn114015-20220503-00384